Evolving Pharmacology Of Depression: Beyond The Monoamine Hypothesis
According to the World Health Organization, major depressive disorder (MDD) currently impacts 300 million individuals worldwide and is the leading cause of disability globally. Current treatment strategies for depression are… Read More